AlphaCentric Advisors’s ADC Therapeutics ADCT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,068,468	Closed	-$958K	–	217
2023 Q3	$958K	Buy	1,068,468 +290,468	+37%	+$261K	0.54%	65
2023 Q2	$1.67M	Buy	778,000 +18,000	+2%	+$38.7K	0.93%	39
2023 Q1	$1.48M	Buy	760,000 +462,500	+155%	+$902K	1.02%	23
2022 Q4	$1.14M	Buy	+297,500	New	+$1.14M	1.13%	27
2021 Q3	–	Sell	-26,000	Closed	-$633K	–	196
2021 Q2	$633K	Buy	26,000 +9,000	+53%	+$219K	0.17%	49
2021 Q1	$415K	Buy	17,000 +13,500	+386%	+$330K	0.14%	53
2020 Q4	$112K	Buy	3,500 +2,500	+250%	+$80K	0.05%	112
2020 Q3	$33K	Buy	+1,000	New	+$33K	0.02%	127